ISPOR Publishes Insights From Its First Global HTA Roundtable

Published Apr 21, 2025

Fostering International Collaboration Among Health Technology Assessment Experts

Lawrenceville, NJ, USA—April 21, 2025—ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) published the insights from its first Global Health Technology Assessment (HTA) Roundtable in an article, “The Importance of Global Collaboration and Knowledge Exchange: A Summary Report of the Global ISPOR HTA Roundtable,” in the March/April issue of Value & Outcomes Spotlight. The Society has a long legacy of convening experts for regional HTA Roundtables across the globe. This was ISPOR’s first globally focused HTA Roundtable.

The virtual ISPOR Global HTA Roundtable convened 100 HTA professionals from 53 countries around the world in Q4 2024 to connect, share best practices, and build consensus on global HTA standards. The Roundtable participants focused on 3 key topics: (1) gene therapies and other advanced therapy medicinal products (ATMPs), (2) improving access to therapies while navigating budget constraints, and (3) digital health with a focus on artificial intelligence (AI).

The participants’ consensus was that there is a strong need for greater international collaboration, transparency, and information sharing to address the common challenges HTA bodies face. The discussions also underscored the importance of adapting HTA methodologies to assess emerging technologies/ATMPs; digital health (including AI); and access to treatments. ISPOR will be holding its next Global HTA Roundtable in 2026 in response to the experts’ strong agreement that more cross-regional collaboration and information sharing was greatly needed.

“ISPOR is committed to supporting events like the Global HTA Roundtable to foster collaboration, consensus, and the evolution of HTA methodologies,” said ISPOR CEO and Executive Director, Rob Abbott. “ISPOR’s Global HTA Roundtable ties directly to 2 objectives in the Society’s new Strategic Plan 2030, including proactively horizon scanning to establish high-leverage health policy opportunities that the Society can contribute toward. It also engages broadly with stakeholders to increase the visibility and influence of health economics and outcomes research, which is vital to HTA.”

Additional information can be found at:
Global HTA Roundtable Report | HTA Strategic Initiative | HEOR by Topic: HTA | Top 10 HEOR Trends Report

###

 

ABOUT ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research
(HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website
 | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram  

Explore Related HEOR by Topic


Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

ISPOR Announces 2026-2027 Board of Directors

May 26, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research announced its 2026-2027 board of directors who will assume office on July 1, 2026.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×